Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Earnings look ahead – Marks & Spencer, Burberry, Barratt Developments

A look at company earnings next week.

Burberry
Source: Bloomberg

Marks & Spencer (Q1 trading statement 11 July)

The full-year results from Marks & Spencer saw a 64% fall in pre-tax profit, as the firm boosted investment, but an 11% rise in full-price clothing and home sales was trumpeted as evidence of real improvement. But the outlook seems tough, with retail sales growing only 0.9% in May, the lowest since April 2013. A robust dividend does not really compensate in the longer-term for a difficult trading environment. CEO Steve Rowe may find that he is not out of the woods yet.

A spike above 390p was defeated at the end of May, with the price heading back into the 313p – 359p range that has held since last summer. A break above 359p still needs to crack the descending trendline off the 2015 highs. Meanwhile, a drop below 313p would clear the way to 256p. 

Burberry (Q1 trading statement 12 July)

Recent changes at the top in Burberry, and a pay dispute, have dominated the news, but the change in management will take time to filter through. Sterling weakness earlier in the year has abated, so there may be a hit to performance. Investors will want to see recent good growth in Asia continue, even if not quite at the same pace. Burberry currently trades at 19.7 times forward earnings per share (EPS), versus 15 times for its broader peer group.

The shares have fallen back to the 200-day simple moving average (SMA), the first time they have touched this since September last year. With momentum now heavily oversold, a bounce is possible, but we will need a push above £16.31. Below the 200-day SMA (currently £16.01), the price could test key support at £15.42.

Barratt Developments (Q4 trading statement 12 July)

Recent updates from Barratt Developments continue to point to a strong trading position, with total forward sales from 1 January to 7 May hitting an all-time high at £3.21 billion, up 12.7% year-on-year. The latest house price index showed that in June growth fell to 2.6%, a four-year low, so there is reason for caution. However, prices are still 9% higher from their pre-recession peak of August 2007, so the longer-term trend is intact. At 9.8 times forward earnings, with a 7% yield the company seems to combine growth and income.

A recent spike higher off the post-July 2016 trendline suggests that we will see the price head back to resistance at 624p, the May high. Only a close back below the late-June low of 555p, which would also put it below the rising trendline, gets the price on a more bearish footing.  

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer